Results 81 to 90 of about 762,366 (142)

Immune pathway activation in gastric cancers with LINE-1 retrotransposon overexpression and homologous recombination deficiency. [PDF]

Exp Mol Med
Kim YJ, Baek IP, Eom BW, Seo MJ, Joo H, Choi YR, Park MK, Oh J, Lee B, Ham SM, Choi NH, Hong SP, Choi J, Kim S, Kong SH, Lee HJ, Suh YS, Kong J, Rhee JK, Lee SW, Yoon HM, Kim HK, Kim YW, Kim JI, Kim BJ, Yang HK.   +25 more
europepmc   +1 more source

Homologous recombination deficiency (HRD) testing of high-grade serous carcinoma using cytological samples. [PDF]

BJC Rep
Demmer I, Schmid MB, Born D, Handschin G, Jochum W.   +4 more
europepmc   +1 more source

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer. [PDF]

Nature
Safonov A, Lee M, Brown DN, Boscolo Bielo L, Mehine M, Bandlamudi C, O'Leary B, Shao H, Vicente L, Muldoon D, Zhu A, Ros S, Marra A, Selenica P, Bieche I, Wubbenhorst B, Ferraro E, Courtois L, El Botty R, Ahmed M, Moiso E, An JA, Donoghue MTA, Will M, Pareja F, Nizialek E, Lukashchuk N, Sofianopoulou E, Liu Y, Huang X, Chappey C, Staniszewska AD, Ross D, Mandelker D, Ladanyi M, Schultz N, Berger MF, Scaltriti M, Reis-Filho JS, Li BT, Offit K, Norton L, Shen R, Maxwell KN, Couch F, Domchek SM, Marangoni E, Shah S, Albertella MR, Serra V, Weigelt B, Solit DB, Nathanson KL, Robson ME, Turner NC, Chandarlapaty S, Razavi P.   +56 more
europepmc   +1 more source

Homologous recombination deficiency testing implementation in the routine clinical setting: real-life experience and lessons learned. [PDF]

ESMO Open
Romero-Lozano P, Gómez-Rey M, Vila-Casadesús M, Martin A, Buono G, Bach V, Onieva A, Ricart M, Deltiempo N, Castillo E, Fariñas L, Aguilar S, Garralda E, Dienstmann R, Nuciforo P, Tabernero J, Garcia-Duran C, Vivancos A.   +17 more
europepmc   +1 more source

Interpreting homologous recombination deficiency in rare gynecological cancers: A case of primary mucinous endometrial adenocarcinoma of gastrointestinal type. [PDF]

Gynecol Oncol Rep
Kabeer F, Cochrane D, Grisdale C, Lynch BJ, McConechy MK, de Barros JS, Zibrik L, Senz J, Jamieson A, McAlpine JN, Gilks B, Marra MA, Laskin J, Drew Y.   +13 more
europepmc   +1 more source

Comprehensive comparison of homologous recombination deficiency predictors in early-stage triple-negative breast cancer. [PDF]

Breast Cancer Res
Nacer DF, Veerla S, Sasiain I, Häkkinen J, Vallon-Christersson J, Rossing M, Nik-Zainal S, Edsjö A, Staaf J.   +8 more
europepmc   +1 more source

Association of germline BRCA and homologous recombination deficiency with hematologic toxicity during platinum-taxane chemotherapy in ovarian cancer. [PDF]

Int J Clin Oncol
Yoshida K, Araki H, Yamada Y, Masahashi Y, Miyamoto E, Katayama K, Kubokawa M, Mogi K, Yoshihara M, Nagao Y, Tamauchi S, Yokoi A, Yoshikawa N, Niimi K, Kajiyama H.   +14 more
europepmc   +1 more source

Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicity. [PDF]

Am J Hum Genet
Schnaiter S, Santer FR, Csanaky KA, Jensen LA, Zeimet AG, Michailidou K, Spurdle AB, Thomassen M.   +7 more
europepmc   +1 more source

Cross-cancer homologous recombination deficiency prediction from whole slide images using transfer learning. [PDF]

Sci Rep
Wang Z, Jiang N, Guo R, Li X, Ye W, Yang S.   +5 more
europepmc   +1 more source

Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy. [PDF]

Oncologist
Mercinelli C, Pavlick D, Agarwal N, Spiess PE, Li R, Kamat AM, Grivas P, Gupta S, Maiorano BA, Tateo V, Cigliola A, Piacentini M, Jacob JM, Bratslavsky G, Basnet A, Ross JS, Necchi A.   +16 more
europepmc   +1 more source